© Wiley Periodicals, Inc.
Edited By: Henrique von Gersdorff
Impact Factor: 2.127
ISI Journal Citation Reports © Ranking: 2014: 170/252 (Neurosciences)
Online ISSN: 1098-2396
Recently Published Issues
The articles below have been specially selected by our editors to highlight to the Synapse community. Read more
Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT
Min-Liang Pan, Meenakshi T. Mukherjee, Himika H. Patel, Bhavin Patel, Cristian C. Constantinescu, M. Reza Mirbolooki, Christopher Liang and Jogeshwar Mukherjee
Sex differences in the ontogeny of CRF receptors during adolescent development in the dorsal raphe nucleus and ventral tegmental area
Jodi L. Lukkes, Kevin J. Norman, Shirisha Meda and Susan L. Andersen
Neuronal changes after chronic high blood pressure in animal models and its implication for vascular dementia
Gonzalo Flores, Gabriel D. Flores-Gómez and Ma. de Jesús Gomez-Villalobos
Modeling and measurement of vesicle pools at the cone ribbon synapse: Changes in release probability are solely responsible for voltage-dependent changes in release
Wallace B. Thoreson, Matthew J. Van hook, Caitlyn Parmelee and Carina Curto
News & Special Features
Synapse is pleased to welcome Erwan Bezard and Benjamin Hall as new Associate Editors
Benjamin Hall is a Principal Scientist at F. Hoffman-La Roche Ltd., working at the Roche Innovation Center Basel, Switzerland. He also holds an Adjunct Professorship in the Cell and Molecular Biology Department and Neuroscience Program at Tulane University in New Orleans, Louisiana. His research investigates the role of NMDA receptors and late-stage transcription factors in the regulation of synaptic function in the cortex with a focus on synapse development and cortical circuit formation in relation to neurodevelopmental disorders. Recent work from his lab is also focused on understanding the cellular mechanisms that initiate the antidepressant actions of low-dose ketamine. He is a National Science Foundation CAREER award recipient, a two-time recipient of the Brain and Behavior Foundation’s NARSAD Young Investigator award, a Grass Foundation Fellow, and previous Staglin Music Festival Investigator.
Erwan Bezard is the Director of the Institute of Neurodegenerative Diseases at University of Bordeaux, which features preclinical and clinical researchers working towards development of therapeutic solutions. He has authored or co-authored over 198 professional publications, most of which are on Parkinson's disease and related disorders. Listed in the Top 1% of the most cited neuroscientists, he is known for his work (i) on the compensatory mechanisms that mask the progression of Parkinson's disease, (ii) on the pathophysiology of levodopa-induced dyskinesia and (iii) on the mechanisms of neurodegeneration in synucleopathies. His current research interests include the study of the levodopa-induced dyskinesia, the intimate mechanisms of cell death in Parkinson’s disease, the modelling of disease progression and the development of new strategies to alleviate symptoms and/or to slow disease progression.